Literature DB >> 7845036

Clinical and radiologic features of cerebral edema in fulminant hepatic failure.

E F Wijdicks1, D J Plevak, J Rakela, R H Wiesner.   

Abstract

OBJECTIVE: To describe a series of consecutive patients with fulminant hepatic failure (FHF) and to present a new classification system for brain edema, an important cause of mortality in such patients.
DESIGN: We reviewed 22 computed tomographic (CT) scans of the brain in 12 patients with FHF and classified the severity of cerebral edema by using predefined criteria.
RESULTS: No cerebral edema was detected on CT scans in four patients with stage 1 or 2 hepatic encephalopathy at the time of admission, but it was noted in seven of eight patients with stage 3 or 4 hepatic encephalopathy. The severity of brain edema on CT scans was significantly correlated (P < 0.001) with the stage of hepatic encephalopathy. Three of the four patients who had stage 1 or 2 hepatic encephalopathy at the time of initial assessment ultimately had a good outcome. Of seven patients with stage 3 encephalopathy, two had rapid deterioration to brain death, three died of nonneurologic causes, and two had a good outcome after liver transplantation. One patient with stage 4 hepatic encephalopathy died, and autopsy showed cerebral edema.
CONCLUSION: Stage 3 or 4 hepatic encephalopathy is associated with cerebral edema that can be detected on CT scans. The clinical and radiologic signs of cerebral edema in patients who have progression to stage 3 hepatic encephalopathy can be reversed with conventional treatment of increased intracranial pressure. Whether early recognition and treatment of cerebral edema result in increased survival of patients with FHF remains to be determined.

Entities:  

Mesh:

Year:  1995        PMID: 7845036     DOI: 10.4065/70.2.119

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  12 in total

Review 1.  Treatment of acute liver failure.

Authors:  K H Boeker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  White matter microsusceptibility changes in patients with hepatic encephalopathy.

Authors:  Adina F Achiriloaie; Daniel Kido; Dan Wycliffe; J Paul Jacobson
Journal:  J Radiol Case Rep       Date:  2011-08-01

3.  Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy.

Authors:  A Huda; R K Gupta; N Rajakumar; M A Thomas
Journal:  Magn Reson Insights       Date:  2008

Review 4.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

5.  Recovery of awareness after hyperacute hepatic encephalopathy with "flat" EEG, severe brain edema and deep coma.

Authors:  Gary R W Hunter; G B Young
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

6.  Intracranial Pressure Monitoring in Acute Liver Failure: Institutional Case Series.

Authors:  Patrick R Maloney; Grant W Mallory; John L D Atkinson; Eelco F Wijdicks; Alejandro A Rabinstein; Jamie J Van Gompel
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

Review 7.  Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

Authors:  V-P Bob Grover; M-Alex Dresner; Daniel-M Forton; Serena Counsell; David-J Larkman; Nayna Patel; Howard-C Thomas; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

8.  Neurogenic diabetes insipidus presenting in a patient with subacute liver failure: a case report.

Authors:  Manu Shankar Hari; Anthony K Parsons; Andy K Burroughs; Steve Shaw; James O'Beirne; Banwari Agarwal
Journal:  J Med Case Rep       Date:  2010-07-30

Review 9.  Acute liver failure including acetaminophen overdose.

Authors:  Robert J Fontana
Journal:  Med Clin North Am       Date:  2008-07       Impact factor: 5.456

10.  23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker.

Authors:  Eric M Liotta; Bryan D Lizza; Anna L Romanova; James C Guth; Michael D Berman; Timothy J Carroll; Brandon Francis; Daniel Ganger; Daniela P Ladner; Matthew B Maas; Andrew M Naidech
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.